What dose of Humalog (insulin lispro) should be given for a blood glucose level of hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dosing for Blood Glucose of 420 mg/dL

For a patient with a blood glucose of 420 mg/dL and a sliding scale that indicates 10 units of Humalog for blood glucose of 400 mg/dL, you should administer 10 units of Humalog (insulin lispro) immediately.

Rationale for Dosing Decision

The patient's blood glucose of 420 mg/dL falls just above the 400 mg/dL threshold on their sliding scale. According to standard sliding scale protocols:

  • When a patient's blood glucose falls between two values on a sliding scale, you should administer the dose corresponding to the lower value 1
  • The sliding scale indicates 10 units of Humalog for blood glucose of 400 mg/dL
  • Since 420 mg/dL is only slightly above 400 mg/dL, the 10 unit dose is appropriate

Administration Considerations

  • Humalog (insulin lispro) is a rapid-acting insulin with onset within 5 minutes, peak action at 1-2 hours, and duration of 3-4 hours 2
  • For hyperglycemia management, Humalog should be administered immediately before or immediately after meals 3
  • In the case of marked hyperglycemia (>250 mg/dL), administering Humalog 15 minutes before meals may provide better postprandial glucose control 4

Monitoring After Administration

After administering the insulin:

  • Monitor blood glucose in 1-2 hours to assess the effectiveness of the dose
  • For hospitalized patients with hyperglycemia, blood glucose monitoring should be performed every 4-6 hours 1
  • Be alert for signs of hypoglycemia (blood glucose <70 mg/dL), which would require immediate intervention

Important Considerations

  1. Avoid relying solely on sliding scale insulin: While addressing the immediate hyperglycemia, be aware that sliding scale insulin alone is not recommended as the sole treatment strategy for diabetes management in hospitalized patients 1

  2. Consider basal-bolus regimen: For ongoing management, a basal-bolus insulin regimen is preferred over sliding scale alone, with approximately 50% of total daily insulin as basal insulin and 50% as prandial insulin 1

  3. Assess for underlying causes: Severe hyperglycemia (>400 mg/dL) may indicate underlying issues that need addressing, such as infection, medication effects, or inadequate baseline insulin regimen

  4. Document the intervention: Record the blood glucose value, insulin dose administered, time of administration, and plan for follow-up monitoring

Hypoglycemia Precautions

If hypoglycemia (<70 mg/dL) occurs after insulin administration:

  • For mild-moderate hypoglycemia (40-70 mg/dL) in conscious patients: administer 15-20g oral carbohydrate
  • For severe hypoglycemia (<40 mg/dL) or unconscious patients: administer IV dextrose 25g or glucagon 1mg IM/SC if IV access is unavailable
  • Recheck blood glucose after 15 minutes and repeat treatment if necessary 1

Remember that Humalog has a rapid onset of action, so close monitoring after administration is essential, especially with high doses used to treat severe hyperglycemia.

References

Guideline

Insulin Management in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.